About Biogenesis
Biogenesis is a Healthcare company based in Poole (United Kingdom) founded in 1984, and was acquired by MorphoSys in January 2005. Custom antibodies are developed and commercialized for research. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is BIOGENESIS LTD.
Company details
Biogenesis was founded in 1984 in Poole, United Kingdom, within the biotechnology sector. Custom antibodies were developed and commercialized by the company for life science research applications. Operations centered on the proprietary huCAL platform, which facilitated rapid and precise production of tailored antibodies. The company was acquired by MorphoSys in February 2005 for 8.6 million.
- Headquarters Poole, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website biogenesis.co.uk
- Acquired by MorphoSys (Jan 2005)
- Legal Name Biogenesis Ltd
Investors in Biogenesis
Biogenesis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MorphoSys.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapeutic antibodies for cancer and other diseases are developed. | 1992 | morphosys.com | Planegg, Germany |
Investor details for Biogenesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biogenesis
2 dated milestones of Biogenesis across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Biogenesis is founded.
- Exit Acquired by MorphoSys.
Web traffic of Biogenesis
Websites that share an audience with Biogenesis (biogenesis.co.uk).
Websites whose visitors overlap most with Biogenesis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mvssolutions.com | mvssolutions.com | 100% | β | ||
ryscor.com | ryscor.com | 100% | β | ||
chemical.net | chemical.net | 100% | #13,416,716 | β | |
anogen.ca | anogen.ca | 59% | β | ||
antibody.bath.ac.uk | antibody.bath.ac.uk | 58% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 9 similar websites and full traffic analytics for Biogenesis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Biogenesis (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biogenesis
Biogenesis was founded in 1984.
Biogenesis is headquartered in Poole, United Kingdom. It is registered at Poole, England, United Kingdom.
Biogenesis was founded in 1984 in Poole, United Kingdom, within the biotechnology sector. Custom antibodies were developed and commercialized by the company for life science research applications. Operations centered on the proprietary huCAL platform, which facilitated rapid and precise production of tailored antibodies. The company was acquired by MorphoSys in February 2005 for 8.6 million.
Biogenesis has 1 investor. Key investors include MorphoSys.
Biogenesis operates through Biogenesis Ltd.
Yes. Biogenesis was acquired by MorphoSys in January 2005.
